| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $45,035,256 ) (Continued on the next page) |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 001 | 4 | NIH | 3/24/2025 | $100,000 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 001 | 4 | NIH | 3/24/2025 | $1 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL167656 | Cardiovascular Risk of Antiretroviral Therapy Drugs in HIV | 001 | 3 | NIH | 5/5/2025 | $65,402 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL167656 | Cardiovascular Risk of Antiretroviral Therapy Drugs in HIV | 000 | 3 | NIH | 3/31/2025 | $588,613 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | U01AI176244 | Autoimmune Drivers and Protectors Team Science (ADAPTS) | 000 | 3 | NIH | 1/23/2025 | $1,249,430 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01EY034946 | Retinal Pigmented Epithelium Epigenome Dysregulation With Aging and Modulation by Diet | 000 | 2 | NIH | 1/23/2025 | $536,749 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | F32AG087622 | Determining the influence of metformin treatment on mitochondrial calcium flux during aerobic exercise training of healthy, aging rats | 000 | 2 | NIH | 6/24/2025 | $50,690 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM152165 | Centromere behaviors that promote proper chromosome segregation in meiosis and mitosis | 001 | 2 | NIH | 12/10/2024 | $383,625 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM152165 | Centromere behaviors that promote proper chromosome segregation in meiosis and mitosis | 002 | 2 | NIH | 8/12/2025 | $42,625 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI172255 | Contributions of autophagy-related genes in lupus | 001 | 3 | NIH | 8/19/2025 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI172255 | Contributions of autophagy-related genes in lupus | 000 | 3 | NIH | 8/5/2025 | $737,898 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG081855 | Mitochondrial NAD+ Metabolism in Cardiac Aging | 001 | 2 | NIH | 7/22/2025 | $47,928 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG081855 | Mitochondrial NAD+ Metabolism in Cardiac Aging | 000 | 2 | NIH | 12/24/2024 | $539,182 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG077812 | A novel role for oxidized lipid mediators as effectors of muscle atrophy and weakness in aging | 000 | 4 | NIH | 8/19/2025 | $535,985 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DA060226 | Effects of tobacco smoking on prognosis and immune function in multiple sclerosis | 000 | 1 | NIH | 5/16/2025 | $552,147 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG074502 | Determining the context specificity of metformin treatment on muscle mitochondria and healthspan | 002 | 4 | NIH | 8/12/2025 | $47,691 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG074502 | Determining the context specificity of metformin treatment on muscle mitochondria and healthspan | 001 | 4 | NIH | 12/19/2024 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG074502 | Determining the context specificity of metformin treatment on muscle mitochondria and healthspan | 000 | 4 | NIH | 12/18/2024 | $536,527 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01EY033782 | Interrogating the intersection between diet and ocular autoimmunity | 000 | 4 | NIH | 4/3/2025 | $541,165 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | DP5OD033443 | Sex chromosomal regulation of hippocampal microglial activation with Alzheimer's disease and aging | 002 | 4 | NIH | 8/28/2025 | $1 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | DP5OD033443 | Sex chromosomal regulation of hippocampal microglial activation with Alzheimer's disease and aging | 002 | 4 | NIH | 8/28/2025 | $873,999 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG074551 | Dissecting the integrated mechanisms of protein turnover to prevent proteostatic decline with aging | 000 | 4 | NIH | 7/10/2025 | $629,177 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL160955 | Increasing glycolysis in the diabetic heart is cardioprotective and improves glucose tolerance | 000 | 4 | NIH | 8/29/2025 | $437,000 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P20GM156711 | Center for Genomic Regulation | 000 | 1 | NIH | 6/10/2025 | $2,463,036 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG070035 | Role of estrogen receptor-a in aging and sex-specific responses to 17a-estradiol | 001 | 5 | NIH | 6/11/2025 | $41,239 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG070035 | Role of estrogen receptor-a in aging and sex-specific responses to 17a-estradiol | 000 | 5 | NIH | 5/7/2025 | $463,921 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01NS121298 | Role of ATAD3A in Lysosomal Homeostasis and Neurogenesis | 000 | 5 | NIH | 8/14/2025 | $433,300 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | K01AR077684 | The role of Fbxl22 in the regulation of skeletal muscle mass | 000 | 5 | NIH | 5/7/2025 | $120,420 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI156724 | Disease and Race Specific Single-cell Epigenetic Mechanisms in Human SLE | 000 | 5 | NIH | 4/16/2025 | $760,427 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AR076440 | Peripheral blood mononuclear cell epigenetic associations in and biomarkers for knee osteoarthritis development and progression | 001 | 7 | NIH | 8/7/2025 | $1,729,917 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P30AR073750 | Oklahoma Rheumatic Disease Research Cores Center | 000 | 8 | NIH | 9/18/2025 | $767,249 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35HL144605 | Protease-Mediated Vascular Instability in Development and Disease | 000 | 7 | NIH | 8/8/2025 | $844,478 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM126980 | Understanding Cell Division | 003 | 7 | NIH | 5/29/2025 | $460,350 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM126980 | Understanding Cell Division | 002 | 6 | NIH | 3/24/2025 | $460,350 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DK085691 | Colon O-glycosylated mucus in the homeostasis of microbiota and host | 000 | 12 | NIH | 8/28/2025 | $731,770 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01NS135830 | Influence of neuromelanin on single dopaminergic neurons in Parkinson's disease. | 000 | 1 | NIH | 1/23/2025 | $616,200 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | RF1AG090599 | A role for mitochondrial AMPK signaling in neurons | 000 | 1 | NIH | 9/10/2025 | $2,602,940 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL175157 | Understanding Sarcoidosis Susceptibility and Disease Burden Through Multi Omics | 000 | 1 | NIH | 8/1/2025 | $778,266 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UM1AI144292 | Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail Success | 003 | 7 | NIH | 8/6/2025 | $400,579 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UM1AI144292 | Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail Success | 002 | 7 | NIH | 5/6/2025 | $767,250 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI191517 | Functional and Mechanistic Characterization of Lupus Susceptibility | 000 | 1 | NIH | 9/3/2025 | $3,364,935 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI190169 | Resolving the mechanisms of IFIH1 risk variant in systemic lupus erythematosus | 000 | 1 | NIH | 9/3/2025 | $700,000 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI190169 | Resolving the mechanisms of IFIH1 risk variant in systemic lupus erythematosus | 000 | 1 | NIH | 9/3/2025 | $2,430,679 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM154839 | Novel pathways in heterochromatin regulation | 000 | 1 | NIH | 8/12/2025 | $426,250 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM160259 | Regulation of gene transcription and DNA replication by chromatin readers from the BET family | 000 | 1 | NIH | 7/31/2025 | $468,875 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01GM157525 | Function and Regulation of DNA Replication Origin Firing Factors | 000 | 1 | NIH | 8/28/2025 | $787,710 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HD110990 | Development of a lacO/lacI based fluorescence reporter-operator system to study chromosome dynamics and double-strand break repair in mouse meiosis. | 001 | 3 | NIH | 4/25/2025 | $36,657 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HD110990 | Development of a lacO/lacI based fluorescence reporter-operator system to study chromosome dynamics and double-strand break repair in mouse meiosis. | 000 | 3 | NIH | 2/13/2025 | $329,918 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21AI194204 | Notch regulation of airway epithelial-immune cell cross-talk in SARS-CoV-2 infection | 000 | 1 | NIH | 7/9/2025 | $448,688 |
|
